2026 Stephen G. Ward: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	52	16647	15286	1315	1217	176	10161

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

16647

15286

1315

1217

176

10161

Biology and Biochemistry

D-Index

Citations

10161

World Ranking

16647

National Ranking

1315

Overview

Stephen G. Ward is affiliated with the University of Bath in the United Kingdom and has contributed extensively to the field of medicine, focusing primarily on oncology, immunology, radiology, public health, and epidemiology.

Their work spans several subfields, including:

Oncology
Immunology
Radiology, Nuclear Medicine and Imaging
Public Health, Environmental and Occupational Health
Epidemiology

Ward's research topics cover diverse areas related to cancer and immune function, including:

Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Immunotherapy and Immune Responses
Radiomics and Machine Learning in Medical Imaging
Immune Cell Function and Interaction
Immune cells in cancer
Hepatocellular Carcinoma Treatment and Prognosis

Their recent publications demonstrate ongoing engagement with cutting-edge biomedical research. Selected recent papers include:

"High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment," 2020, published in Cancer Research
"High-frequency Ultrasound Assessment of Systemic Sclerosis Skin Involvement: Intraobserver Repeatability and Relationship With Clinician Assessment and Dermal Collagen Content," 2020, published in The Journal of Rheumatology
"Quantification of biomarker functionality predicts patient outcomes," 2021, published in British Journal of Cancer
"Gut microbiome in two high-altitude bird populations showed heterogeneity in sex and life stage," 2024, published in FEMS Microbes
"Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosis," 2023, published in Frontiers in Immunology

Ward has frequently collaborated with several researchers, including:

Banafshé Larijani
James Miles
Thomas U. Marron
Maria Isabel Fiel
Christopher J. Applebee

Their work has been published repeatedly in venues such as:

Regular and Young Investigator Award Abstracts
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research
The Journal of Rheumatology
FEMS Microbes

Best Publications

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

Carolyn S Calfee;Kevin L Delucchi;Pratik Sinha;Michael A Matthay

715
Citations
Chemokines and T lymphocytes: more than an attraction.

Stephen G Ward;Kevin Bacon;John Westwick

562
Citations
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle

George Kolios;Vassilis Valatas;Stephen G. Ward

560
Citations
Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing

Karen Wright;Nicholas Rooney;Mark Feeney;Jeremy Tate

423
Citations
The CXC Chemokine Stromal Cell-Derived Factor Activates a Gi-Coupled Phosphoinositide 3-Kinase in T Lymphocytes

Yannis Sotsios;Gillian C. Whittaker;John Westwick;Stephen G. Ward

323
Citations
Chemokines: understanding their role in T-lymphocyte biology

Stephen G. Ward;John Westwick

297
Citations
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents.

Stephen G Ward;Peter Finan

256
Citations
The CC Chemokine Monocyte Chemotactic Peptide-1 Activates both the Class I p85/p110 Phosphatidylinositol 3-Kinase and the Class II PI3K-C2α

Sarah J. Turner;Jan Domin;Michael D. Waterfield;Stephen G. Ward

234
Citations
PI 3-kinase: a pivotal pathway in T-cell activation?

Stephen G. Ward;Carl H. June;Daniel Olive

218
Citations
Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases

Adam P Curnock;Marisa K Logan;Stephen G Ward

217
Citations
CD28: a signalling perspective.

Stephen G Ward

211
Citations
Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.

Yannis Sotsios;Stephen G. Ward

204
Citations
RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase.

L Turner;S G Ward;J Westwick

201
Citations
Therapeutic potential of phosphoinositide 3-kinase inhibitors.

Stephen Ward;Yannis Sotsios;James Dowden;Ian Bruce

190
Citations
PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models.

Emmanuelle Astoul;Catherine Edmunds;Doreen A. Cantrell;Stephen G. Ward

172
Citations
Ligation of CD28 receptor by B7 induces formation of D‐3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation

Stephen G. Ward;John Westwick;Nicolas D. Hall;David M. Sansom

163
Citations
Ligation of the T cell co‐stimulatory receptor CD28 activates the serine‐threonine protein kinase protein kinase B

Richard V. Parry;Karin Reif;Graham Smith;David M. Sansom

163
Citations
Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase Effectors

Robin W. Freeburn;Karen L. Wright;Steven J. Burgess;Emmanuelle Astoul

157
Citations
Do phosphoinositide 3-kinases direct lymphocyte navigation?

Stephen G. Ward

152
Citations
Phosphoinositide 3-kinases in T lymphocyte activation

Stephen G Ward;Doreen A Cantrell

147
Citations